Developing vaccines to prevent Chlamydia infections
Official title: Bacteriophage virus-like particle vaccines for Chlamydia trachomatis urogenital infection
Funded at University of New Mexico Health Scis Ctr · NIH-10991328 · Data updated 2026-11-12
This study is looking at how to create vaccines that help your immune system fight off Chlamydia, a common sexually transmitted infection, to prevent serious health issues like infertility.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of New Mexico Health Scis Ctr NIH-funded |
| Lab location | 1 site (Albuquerque, United States) |
| Project start | December 6, 2022 |
| Project end | November 30, 2027 |
| Funding year | 2025 |
| Award (this year) | $371,365 |
| NIH project number | 5R01AI166360-03 |
| Project ID | NIH-10991328 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are sexually active individuals, particularly women, who are at risk of Chlamydia infections.
✕Less likely to help
Patients who are already infected with Chlamydia or those who have had previous infections may not benefit from this preventive vaccine.
What this research studies
This research focuses on creating vaccines that can stimulate the immune system to produce antibodies against Chlamydia trachomatis, a common sexually transmitted infection. The study aims to understand how the immune system responds to this infection and to identify specific proteins that can be targeted by vaccines. By engineering vaccine candidates that elicit strong antibody responses, the research seeks to provide a preventive measure against the serious health complications associated with Chlamydia, such as infertility and pelvic inflammatory disease.
Why it matters
Potential benefit: If successful, this research could lead to an effective vaccine that prevents Chlamydia infections and their associated long-term health issues.
How similar studies have gone: While there have been various approaches to developing vaccines for sexually transmitted infections, this specific method targeting Chlamydia is novel and has not been extensively tested.
Where this research is happening
-
University of New Mexico Health Scis Ctr
Albuquerque, United States Active
Researchers
- Principal investigator: Frietze, Kathryn M. — University of New Mexico Health Scis Ctr
- Study coordinator: Frietze, Kathryn M.
Related research
Other NIH-funded projects on the same topics.
-
Investigating how a specific signaling molecule affects brain blood vessel health in dementia.
This study is looking at how a substance called sphingosine 1 phosphate (S1P) might help protect the blood-brain barrier and improve brain health for people with Cerebral Small Vessel Disease, which can lead to dementia, and it hopes to find new ways to slow down or prevent this condition.
-
Administrative Core for a Cancer Research Program
This NIH grant funds an Administrative Core to manage a large cancer research program and ensure compliance, coordination, and data resources to support studies on cancer causes and patient populations.
-
Administrative Core for a cancer research program
A central hub at a major medical center helps coordinate cancer research, data resources, and compliance to accelerate progress for people affected by cancer.
-
Engagement Optimization for AI/AN Cancer Genomics and Care
A patient-friendly project aims to use AI tools to better understand cancer genetics in American Indian and Alaska Native communities and use that knowledge to improve screening, prevention, and treatment.
-
GenomeCharacterization for AI/AN Cancer Health
A large NIH project aims to map the cancer genomes of American Indian and Alaska Native people to uncover unique mutations and patterns that could improve cancer screening, prevention, and treatment for AI/AN communities.
-
Engaging AI/AN Communities in Cancer Genomics for Better Screening and Care
A community-engaged research effort to understand cancer genetics in American Indian and Alaska Native people with the goal of improving screening, prevention, and treatment.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.